DS
KBIO

David Shaw’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

David Shaw’s Portfolio KBIO Stock Details KBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,466
Closed -$20K – 4387
2014
Q4 		$20K Sell
1,466
-156
-10% -$2.23K ﹤0.01% 3955
2014
Q3 		$20K Sell
1,622
-25
-2% -$345 ﹤0.01% 4044
2014
Q2 		$30K Buy
+1,647
New +$28.2K ﹤0.01% 4125

Other funds holding KBIO

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $944M AUM 90.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

David Shaw's KBIO Position: Q1 2015 in Review

David Shaw sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2015, closing a stake of 1,466 shares — an estimated $20K sold.

David Shaw first reported a position in KBIO in Q2 2014 and held it in 3 quarters. The position peaked at $30K in Q2 2014. 24 funds tracked by Wall St. Rank hold KBIO as of Q1 2015.

  • David Shaw reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2015 after selling out during the quarter.
  • David Shaw sold 1,466 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2015, an estimated $20K.
  • David Shaw first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q2 2014 and held it in 3 quarters.
  • David Shaw's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $30K in Q2 2014.
  • 24 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2015.

Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.